Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

MY33-3

🥰Excellent
Catalog No. T39677Cas No. 2204280-41-9
Alias MY33-3

MY33-3 is a powerful and specific inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, demonstrating an IC50 value of approximately 0.1 μM. Moreover, MY33-3 exhibits inhibitory activity against PTP-1B with an IC50 value of about 0.7 μM. Additionally, MY33-3 has been shown to effectively decrease ethanol consumption and alleviate neuroinflammation and cognitive dysfunction induced by Sevoflurane.

MY33-3

MY33-3

🥰Excellent
Catalog No. T39677Alias MY33-3Cas No. 2204280-41-9
MY33-3 is a powerful and specific inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, demonstrating an IC50 value of approximately 0.1 μM. Moreover, MY33-3 exhibits inhibitory activity against PTP-1B with an IC50 value of about 0.7 μM. Additionally, MY33-3 has been shown to effectively decrease ethanol consumption and alleviate neuroinflammation and cognitive dysfunction induced by Sevoflurane.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
MY33-3 is a powerful and specific inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, demonstrating an IC50 value of approximately 0.1 μM. Moreover, MY33-3 exhibits inhibitory activity against PTP-1B with an IC50 value of about 0.7 μM. Additionally, MY33-3 has been shown to effectively decrease ethanol consumption and alleviate neuroinflammation and cognitive dysfunction induced by Sevoflurane.
Targets&IC50
RPTPβ/ζ:0.1 μM (IC50), PTP1B:0.7 μM (IC50)
In vitro
MY33-3, at a concentration of 1 μM with a pretreatment time of 5 minutes, inhibits the ethanol-induced activation of TrkA and ALK in SH-SY5Y cells without altering the overall protein levels of TrkA and ALK. Furthermore, MY33-3, within a concentration range of 0.1-10 μM over 24 hours, reduces LPS-induced nitrite production and the increase of iNOS in BV2 microglial cells. In a cell viability assay conducted on SH-SY5Y cells with a 1 μM concentration of MY33-3 pretreated for 5 minutes and co-treated for 15 minutes, the compound decreased the ethanol-induced activation of TrkA and ALK, indicating no significant effect on the total protein levels of TrkA or ALK.
In vivo
Administered orally (p.o.) at a dosage of 60 mg/kg on days 3 and 4, MY33-3 notably decreases ethanol consumption in male C57BL/6J mice (8-10 weeks old) undergoing a two-bottle drinking in the dark (DID) procedure with 20% ethanol. This comparison highlights a significant reduction in ethanol intake from day 2 to day 3 and a diminished preference for the ethanol solution by day 3, without impacting the overall fluid consumption. Furthermore, MY33-3 (administered intraperitoneally (i.p.)) counteracts the decline in discrimination index and the deterioration of motor learning abilities induced by Sevoflurane, illustrating its potential in reversing cognitive impairments associated with substance exposure.
AliasMY33-3
Chemical Properties
Molecular Weight397.4
FormulaC16H13F6NS2
Cas No.2204280-41-9
Relative Density.1.41 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MY33-3 | purchase MY33-3 | MY33-3 cost | order MY33-3 | MY33-3 chemical structure | MY33-3 in vivo | MY33-3 in vitro | MY33-3 formula | MY33-3 molecular weight